Search

Your search keyword '"Diker, Dror"' showing total 11 results
Start Over Author "Diker, Dror"
11 results on '"Diker, Dror"'

2. An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease

Author

Mastboim, Niv Samuel, Angel, Alon, Shaham, Oded, Ber, Tahel Ilan, Navon, Roy, Simon, Einav, Rosenberg, Michal, Israeli, Yael, Hainrichson, Mary, Avni, Noa, Reiner, Eran, Feigin, Paul, Oved, Kfir, Tadmor, Boaz, Singer, Pierre, Kagan, Ilya, Lev, Shaul, Diker, Dror, Jarjou'I, Amir, Kurd, Ramzi, Ben-Chetrit, Eli, Danziger, Guy, Tegethoff, Sina A., Papan, Cihan, Motov, Sergey, Shapira, Ma'anit, Stein, Michal, Gottlieb, Tanya M., Eden, Eran, and Klein, Adi

Published
2023
Full Text
View/download PDF

4. Statistical power boost for broadly applicable host immune response-based tools

Author

Mastboim, Niv, primary, Angel, Alon, additional, Shaham, Oded, additional, Ilan Ber, Tahel, additional, Navon, Roy, additional, Simon, Einav, additional, Rosenberg, Michal, additional, Israeli, Yael, additional, Hainrichson, Mary, additional, Avni, Noa, additional, Reiner, Eran, additional, Feigin, Paul, additional, Oved, Kfir, additional, Tadmor, Boaz, additional, Singer, Pierre, additional, Kagan, Ilya, additional, Lev, Shaul, additional, Diker, Dror, additional, Jarjou’i, Amir, additional, Kurd, Ramzi, additional, Ben-Chetrit, Eli, additional, Danziger, Guy, additional, Papan, Cihan, additional, Motov, Sergey, additional, Shapira, Ma’anit, additional, Stein, Michal, additional, Klein, Adi, additional, Gottlieb, Tanya, additional, and Eden, Eran, additional

Published
2022
Full Text
View/download PDF

5. 32. Host Immune-Protein Signature Combining TRAIL, IP-10 and CRP for Early and Accurate Prediction of Severe COVID-19 Outcome

Author

Angel, Alon, primary, Mastboim, Niv Samuel, additional, Shaham, Oded, additional, Ber, Tahel Ilan, additional, Navon, Roy, additional, Simon, Einav, additional, Rosenberg, Michal, additional, Israeli, Yael, additional, Hainrichson, Mary, additional, Avni, Noa, additional, Reiner, Eran, additional, Feigin, Paul, additional, Oved, Kfir, additional, Tadmor, Boaz, additional, Singer, Pierre, additional, Kagan, Ilya, additional, Lev, Shaul, additional, Diker, Dror, additional, Jarjou’i, Amir, additional, Kurd, Ramzi, additional, Ben-Chetrit, Eli, additional, Danziger, Guy, additional, Papan, Cihan, additional, Motov, Sergey, additional, Shapira, Maanit, additional, Stein, Michal, additional, Klein, Adi, additional, Gottlieb, Tanya, additional, and Eden, Eran, additional

Published
2021
Full Text
View/download PDF

6. An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcome

Author

Mastboim, Niv Samuel, primary, Angel, Alon, additional, Shaham, Oded, additional, Ber, Tahel Ilan, additional, Navon, Roy, additional, Simon, Einav, additional, Rosenberg, Michal, additional, Israeli, Yael, additional, Hainrichson, Mary, additional, Avni, Noa, additional, Reiner, Eran, additional, Feigin, Paul, additional, Oved, Kfir, additional, Tadmor, Boaz, additional, Singer, Pierre, additional, Kagan, Ilya, additional, Lev, Shaul, additional, Diker, Dror, additional, Jarjou’i, Amir, additional, Kurd, Ramzi, additional, Ben-Chetrit, Eli, additional, Danziger, Guy, additional, Papan, Cihan, additional, Motov, Sergey, additional, Shapira, Ma’anit, additional, Stein, Michal, additional, Klein, Adi, additional, Gottlieb, Tanya M, additional, and Eden, Eran, additional

Published
2021
Full Text
View/download PDF

9. Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19

Author

Lev, Shaul, primary, Gottesman, Tamar, additional, Sahaf Levin, Gal, additional, Lederfein, Doron, additional, Berkov, Evgeny, additional, Diker, Dror, additional, Zaidman, Aliza, additional, Nutman, Amir, additional, Ilan Ber, Tahel, additional, Angel, Alon, additional, Kellerman, Lior, additional, Barash, Eran, additional, Navon, Roy, additional, Boico, Olga, additional, Israeli, Yael, additional, Rosenberg, Michal, additional, Gelman, Amir, additional, Kalfon, Roy, additional, Simon, Einav, additional, Avni, Noa, additional, Hainrichson, Mary, additional, Zarchin, Oren, additional, Gottlieb, Tanya M., additional, Oved, Kfir, additional, Eden, Eran, additional, and Tadmor, Boaz, additional

Published
2021
Full Text
View/download PDF

10. Real-time IP-10 measurements as a new tool for inflammation regulation within a clinical decision support protocol for managing severe COVID-19 patients

Author

Lev, Shaul, primary, Gottesman, Tamar, additional, Levin, Gal Sahaf, additional, Lederfein, Doron, additional, Berkov, Evgeny, additional, Diker, Dror, additional, Zaidman, Aliza, additional, Nutman, Amir, additional, Ber, Tahel Ilan, additional, Angel, Alon, additional, Kellerman, Lior, additional, Barash, Eran, additional, Navon, Roy, additional, Boico, Olga, additional, Israeli, Yael, additional, Rosenberg, Michal, additional, Gelman, Amir, additional, Kalfon, Roy, additional, Simon, Einav, additional, Avni, Noa, additional, Hainrichson, Mary, additional, Zarchin, Oren, additional, Gottlieb, Tanya M., additional, Oved, Kfir, additional, Eden, Eran, additional, and Tadmor, Boaz, additional

Published
2020
Full Text
View/download PDF

11. [IMPACT OF CLINICAL PHARMACIST CONSULTATIONS ON RATE OF COMPLICATIONS, RE-HOSPITALIZATIONS AND MORTALITY IN PATIENTS UNDERGOING BARIATRIC SURGERY].

Author

Dahan AE, Dahan A, Shimoni O, Diker D, Mahler I, Marcoviciu DD, Hammerman A, and Azran C

Subjects
Humans, Retrospective Studies, Pharmacists, Hospitalization, Chronic Disease, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Complications prevention & control, Obesity, Morbid surgery, Bariatric Surgery adverse effects, Bariatric Surgery methods
Abstract

Background: Patients undergoing bariatric surgery are prone to changes in absorption, improvement in their chronic diseases and other pharmacokinetic/pharmacodynamic alteration which can affect continuation and the required doses of their chronic medications., Objectives: To examine the effect of a clinical pharmacist's consultation on the rate of complications, re-hospitalizations and mortality among patients who underwent bariatric surgery., Methods: In this retrospective cohort study, results of bariatric patients who were consulted by a clinical pharmacist between the years 2013-2019 were compared with the results of a wider group of bariatric patients with chronic diseases who were recorded in the Israeli General Bariatric Registry during the same years. The intervention cohort included bariatric patients members of Clalit Health Services, who were treated at the Herzliya Medical Center and who were identified by the treating staff as complex cases requiring drug counseling. The primary outcomes measured in the study included: rates of surgical complications, re-hospitalizations, and death up to one year after surgery., Results: The intervention group included 165 patients; the 12 month rate of re-hospitalization in the intervention group was 10.9% vs. 19.5% in the comparison group (p=0.005). The rate of documented postoperative complications was 2.7% vs. 3.9% (p=0.462) and mortality was null vs. 0.16%., Conclusions: Although the intervention population was identified in advance as more complex in terms of age and background morbidity, the rate of re-hospitalization and mortality was significantly lower in the intervention group than in the general bariatric surgery population in Israel. These results demonstrate the importance of referring to a specialized clinical pharmacist around bariatric surgery for improving patient safety, especially in complex patients.

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results